加用疗法治疗子宫内膜异位症：北美经验 - Suppr | 超能文献

Add-back therapy in the treatment of endometriosis: the North American experience.

作者信息

Moghissi K S

机构信息

Wayne State University, School of Medicine, Detroit, MI, USA.

出版信息

Br J Obstet Gynaecol. 1996 Oct;103 Suppl 14:14.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Add-back therapy in the treatment of endometriosis: the North American experience.加用疗法治疗子宫内膜异位症：北美经验

Br J Obstet Gynaecol. 1996 Oct;103 Suppl 14:14.

2

Add-back therapy in the treatment of endometriosis: the European experience.子宫内膜异位症治疗中的补充疗法：欧洲经验

Br J Obstet Gynaecol. 1996 Oct;103 Suppl 14:10-3.

3

Should add-back therapy for endometriosis be deferred for optimal results?子宫内膜异位症的补充治疗是否应推迟以获得最佳效果？

Br J Obstet Gynaecol. 1996 Oct;103 Suppl 14:15-7.

4

[Effects and safety of gonadotrophin-releasing hormone agonist combined with estradiol patch and oral medroxyprogesterone acetate on endometriosis].促性腺激素释放激素激动剂联合雌二醇贴片及口服醋酸甲羟孕酮治疗子宫内膜异位症的疗效及安全性

Zhonghua Fu Chan Ke Za Zhi. 2009 Jul;44(7):504-8.

5

The need for add-back with gonadotrophin-releasing hormone agonist therapy.促性腺激素释放激素激动剂治疗中进行补充治疗的必要性。

Br J Obstet Gynaecol. 1996 Oct;103 Suppl 14:1-4.

6

Can hormone replacement therapy be used during medical therapy of endometriosis?子宫内膜异位症药物治疗期间可以使用激素替代疗法吗？

Br J Obstet Gynaecol. 1994 May;101 Suppl 10:24-6. doi: 10.1111/j.1471-0528.1994.tb13681.x.

7

Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.促性腺激素释放激素类似物（戈舍瑞林）加激素替代疗法治疗子宫内膜异位症：一项随机对照试验

Fertil Steril. 1995 Sep;64(3):474-81. doi: 10.1016/s0015-0282(16)57779-6.

8

Add-back therapy for long-term use in dysfunctional uterine bleeding and uterine fibroids.加用疗法在功能失调性子宫出血和子宫肌瘤中的长期应用。

Br J Obstet Gynaecol. 1996 Oct;103 Suppl 14:18-21.

9

Gonadotropin-releasing hormone agonist plus "add-back" hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial.促性腺激素释放激素激动剂联合“反向添加”激素替代疗法治疗子宫内膜异位症：一项前瞻性、随机、安慰剂对照、双盲试验。

Fertil Steril. 2000 Sep;74(3):534-9. doi: 10.1016/s0015-0282(00)00690-7.

10

Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis.醋酸戈舍瑞林单一促性腺激素释放激素激动剂与戈舍瑞林联合雌激素-孕激素反向添加疗法治疗子宫内膜异位症的比较。

Fertil Steril. 1995 Nov;64(5):903-8. doi: 10.1016/s0015-0282(16)57900-x.

引用本文的文献

1

Evaluation, validation and refinement of noninvasive diagnostic biomarkers for endometriosis (ENDOmarker): A protocol to phenotype bio-specimens for discovery and validation.子宫内膜异位症非侵入性诊断生物标志物的评估、验证与优化（ENDOmarker）：一项用于生物样本表型分析以进行发现和验证的方案

Contemp Clin Trials. 2018 May;68:1-6. doi: 10.1016/j.cct.2018.03.002. Epub 2018 Mar 7.

2

Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density.用于子宫内膜异位症的促性腺激素释放激素类似物：骨矿物质密度

Cochrane Database Syst Rev. 2003;2003(4):CD001297. doi: 10.1002/14651858.CD001297.